Immunological Properties of Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Strain Expressing Fusion Protein IL-2-ESAT-6

The live vaccine Mycobacterium bovis bacillus Calmette-Guérin (BCG) provides variableefficacy against adult pulmonary tuberculosis (TB).Recombinant BCG,expressing either immunodominantantigens or Th1 cytokines,is a promising strategy for developing a new TB vaccine.However,not much isknown about whether the introduction of cytokine and specific antigen genes concurrently into the BCGstrain could improve the immunogenicity of BCG.In this study,a recombinant BCG strain (rBCG) expressingthe fusion protein human interleukin (IL)-2 and ESAT-6 (early secreted antigenic target-6 kDa) antigen ofMycobacterium tuberculosis was constructed.Six weeks after BALB/c mice (H-2~d) were immunizedwith 10~6 colony forming units (CFUs) BCG or rBCG,splenocyte proliferation was determined with MTT[3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide] assay,IL-4 and interferon (IFN)-γproducedby splenocytes were tested by enzyme linked immunosorbent assay (ELISA,) and the cytotoxicity ofsplenocytes from immunized mice to P815 cells (H-2~d) expressing ESAT-6 protein was measured usingCytoTox 96 Non-Radioactive Cytotoxicity Assay.Compared with native BCG-vaccinated mice,rBCG inducedstronger Th1 responses that were confirmed by high lymphoproliferative responses and IFN-γproductionto culture filtrate protein (CFP) or ESAT-6 protein.Moreover,rBCG induced significant enhanced CTLresponses against P815-ESAT-6 cells.Results from rBCG-immunized mice demonstrated that introducingthe il-2 and esat-6 genes into BCG could enhance Th1 type immune responses to ESAT-6.Further investigationis needed by introducing other Th1 cytokines and antigens into BCG to optimize the protective efficacyagainst TB.     

Fractogel EMD“触角型”阴离子交换介质用于病毒纯化和去除

Fractogel EMD是合成的聚甲基丙烯酸酯树脂，十几个官能团排布在线形聚合物长链上，称为“触角”，所有的“触角”都是通过共价键结合到聚合物骨架上，生物分子更加容易和“触角型”介质的官能团结合，并且可以大大降低生物分子和介质基质的非特异性相互作用，提高生物分子的回收率。     

流感病毒抑制剂的研究进展

流感病毒(Influenza Virus,IVs)属于正黏病毒科(Orthomyyxoviridae),单股负链RNA包膜病毒,由于其传播和变异速度快,且致病力和致死率高,严重威胁人类的健康和生命.理论上,抑制流感病毒生命周期的任何一个阶段,都可以有效地抑制病毒的复制和传播.目前FDA已批准的药物主要作用于子代病毒的释放阶段,随着流感病毒耐药问题的日益严重,不同作用机制的抑制剂不断被发现,部分已经进入临床研究阶段.新技术、新思路持续推进着流感病毒抑制剂的研究,本文将对最新的流感病毒抑制剂研究进展进行综述,旨在为新型的流感病毒抑制剂的设计和研发提供参考和思路.     

N-糖蛋白去糖基化酶（PNGase）的研究进展

N-糖蛋白去糖基化酶（PNGase）是一种广泛存在于真菌、植物、哺乳动物中的去糖基化酶，可以水解N-糖蛋白或 N-糖肽上天冬酰胺与寡糖链连接的化学键，并释放出完整的N-寡糖。PNGase在生物体内参与蛋白质降解、器官发育、个体生长等过程。人PNGase基因功能缺陷会导致先天性去糖基化障碍，小鼠PNGase缺陷会导致胚胎致死性，线虫PNGase缺陷使其寿命下降。本文对PNGase在不同物种的分布、蛋白质结构、酶学功能及生物学功能进行阐述，为PNGase的生理病理功能及致病机制的基础研究提供思路，为PNGase作为糖生物学工具酶或药物开发的创新应用研究奠定基础。     

The RAF family：an expanding network of post—traslational controls and protein—protein interactions

Protein kinase RAF is strategically located in the “Ras-MAP-kinase signal transduction pathway“,a principle system which transmits signals from growth factor receptors to the nucleus,resulting in cell proliferation.Growth factor responses are mediated in part by activation of Ras,which in turn activates RAF to phosphorylate MEK,its downstream substrate.MEK activates MAPkinase to in fluence nuclear events.it is clear.however,that a network of signals other than those carred by Ras plays a role in RAF regulation.These orthogonal influences are mediated bu:serine/threonine kinases,tyrosine kinases,and protein-protein interactions.As a further complication to the RAF network,three isoforms of RAF have been established which have divergent N-terminal regulatory domains,Whereas these divergent regulatory domains implicate isoform-specific functions,no clear evidence or hypothesis for distinct functions for individual isoforms has been presented.Recently,“isoform-specific protein interactions“have been identified among numerous proteins interacting with RAF,These studies may serve to delineate independent functions for RAF isoforms.